Expression of AXIN2, a marker for Wnt pathway activation [39]–[41], was generally higher in pancreatic adenocarcinomas compared to primary pancreatic duct cells (Figure 5). The gene discussed is AXIN2; the disease is pancreatic adenocarcinoma.